Kemnay Advisory Services Inc. Neurocrine Biosciences Inc Transaction History

Kemnay Advisory Services Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $412,718 - $580,063	-4,292 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $482,970 - $739,923	-5,676 Reduced 56.94%	4,292 $524,000
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $613,798 - $929,646	-8,172 Reduced 45.05%	9,968 $863,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $1.57 Million - $2.15 Million	18,140 New	18,140 $1.95 Million

637

93.8M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.4B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Kemnay Advisory Services Inc., based on Form 13F filings with the SEC.

Stay updated on Kemnay Advisory Services Inc. with notifications on news.